IOVANCE BIOTHERAPEUTICS, INC. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

IOVANCE BIOTHERAPEUTICS, INC. reported Revenue From Contract With Customer Excluding Assessed Tax of $263.50 million for the year ending 2025.

  • IOVANCE BIOTHERAPEUTICS, INC. showed an increase of +60.6% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
  • This data is from IOVANCE BIOTHERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
  • XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2023 to 2025), IOVANCE BIOTHERAPEUTICS, INC.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 22,061.6%.
  • Historical annual values: Fiscal year 2025: $263.50 million | Fiscal year 2024: $164.07 million | Fiscal year 2023: $1.19 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: